Topics

Opinion: The coronavirus outbreak exposes the U.S.’s pharma supply chain vulnerability

04:40 EST 14 Feb 2020 | STAT

400,000 new jobs have been created in the U.S. domestic manufacturing sector. We must focus this momentum and begin bringing pharmaceutical manufacturing jobs back to the U.S.

Original Article: Opinion: The coronavirus outbreak exposes the U.S.’s pharma supply chain vulnerability

NEXT ARTICLE

More From BioPortfolio on "Opinion: The coronavirus outbreak exposes the U.S.’s pharma supply chain vulnerability"

Quick Search